By Sherri Oslick —

About
Court Report:  Each week we will report briefly on recently filed
biotech and pharma cases, and a few interesting cases will be selected
for periodic monitoring.

Purdue Pharma LP et al. v. Apotex Inc. et al.
1:07-cv-00549; filed September 12, 2007 in the District Court of Delaware

Infringement of U.S. Patent No. 5,508,042 ("Controlled Release Oxycodone Compositions," issued April 16, 1996) following a paragraph IV certification as part of Apotex’s filing of an ANDA to manufacture a generic version of Purdue Pharma’s OxyContin® (controlled release oxycodone hydrochloride, used to treat pain).  View the complaint here.

Hoffmann-La Roche Inc. v. Gate Pharmaceuticals et al.
2:07-cv-04285; filed September 7, 2007 in the District Court of New Jersey

Hoffmann-La Roche Inc. v. Teva Pharmaceurticals USA, Inc. et al.
2:07-cv-04284; filed September 7, 2007 in the District Court of New Jersey

Hoffman-La Roche Inc. v. Mutual Pharmaceutical Company, Inc. et al.
2:07-cv-04350; filed September 11, 2007 in the District Court of New Jersey

The complaints in these cases are substantially similar.  Infringement of U.S. Patent Nos. 7,192,938 ("Method of Treatment Using Bisphosphonic Acid," issued March 20, 2007) and 6,294,196 ("Pharmaceutical Composition Containing Diphosphonic Acid or Salt Thereof," issued September 25, 2001) following a paragraph IV certification as part of defendants’ filing of an ANDA to manufacture a generic version of Roche’s Boniva® (ibandronate sodium, used to treat post-menopausal osteoporosis).  View the Gate Pharmaceuticals complaint here.